Amicus Therapeutics (FOLD)

• Market cap: $4.54B
• 1 day: 0.07%
• 5 days: -0.07%
• 1 month: 0.63%
• 3 months: 1.05%
• 6 months: 79.85%
• Year to date: 1.33%
• 1 year: 111.71%
• 5 years: 46.06%
• 10 years: 83.04%
• Sector: Healthcare
• Industry: Biotechnology

About: Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Employees: 511